JB Chemicals & Pharmaceuticals Ltd (JBCHEPHARM)

JB Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) is listed on the NSE in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry. Market capitalisation: 38730.77 Cr. Figures below are as reported and are shown with their source and date.

Educational use only — GoQuant is a research tool. This page lists company facts only and is not a recommendation. Investment advice is provided by FINOME TECHNOLOGIES PVT LTD (AltQube), SEBI-registered Investment Adviser, registration no. INA000018373, under a signed advisory agreement and after a risk profile. Past performance is not indicative of future results.

Company profile

Sector
Pharmaceuticals
Industry
Pharmaceuticals & Biotechnology
Market cap (₹ Cr)
38,730.77

JB Chemicals & Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and trade of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 5,095 full-time employees. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The firm is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). The company is involved in the provision of product development services. The firm offers varied products and dosage forms across therapeutic categories, which includes gastroenterology, hypertension, dermatology, nephrology, respiratory, virology, diabetes, wound care, anti-infectives, pharmacovigilance and nicotine replacement therapy (NRT). Its offers lozenges, which includes center-filled, soft-centered lozenges, center-filled, powder lozenges, herbal lozenges, and medicated lozenges. Its APIs products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Diclofenac Potassium, Nifedipine, Atenolol, Cilnidipine, and Ciprofloxacin HCl. The firm also owns Razel (Rousvastatin) franchise for the India and Nepal.

Source: finedge · as of 2026-09-29

Price, last year

no_verified_figure

Last close (₹): 2,509

Source: quantro_screener_metrics_job · as of 2026-07-15

Key figures

P/E
56.78
52-week high
2,510
52-week low
1,603.5
Revenue CAGR, 3 years (%)
9.61
Revenue CAGR, 5 years (%)
15.22
EPS CAGR, 3 years (%)
18.61
EPS CAGR, 5 years (%)
8.8

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Year endedRevenue (₹ Cr)PAT (₹ Cr)EPS (₹)
Mar 20264,147.79709.4744.19
Mar 20253,917.99659.5842.37
Mar 20243,484.18552.6335.61
Mar 20233,149.28409.8326.48
Mar 20222,424.24385.3624.93

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter
48.8%
FII
16.33%
DII
21.38%
Public
13.48%
Promoter shares pledged
0%

Source: finedge · as of 2026-03-31

Similar companies

Source: quantro_company_profiles · as of 2026-10-23

Frequently asked questions

What does JB Chemicals & Pharmaceuticals Ltd do?
JB Chemicals & Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and trade of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 5,095 full-time employees. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The firm is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). The company is involved in the provision of product development services. The firm offers varied products and dosage forms across therapeutic categories, which includes gastroenterology, hypertension, dermatology, nephrology, respiratory, virology, diabetes, wound care, anti-infectives, pharmacovigilance and nicotine replacement therapy (NRT). Its offers lozenges, which includes center-filled, soft-centered lozenges, center-filled, powder lozenges, herbal lozenges, and medicated lozenges. Its APIs products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Diclofenac Potassium, Nifedipine, Atenolol, Cilnidipine, and Ciprofloxacin HCl. The firm also owns Razel (Rousvastatin) franchise for the India and Nepal.
Which sector is JB Chemicals & Pharmaceuticals Ltd in?
JB Chemicals & Pharmaceuticals Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.
What are JB Chemicals & Pharmaceuticals Ltd's latest annual revenue and profit?
For the year ended Mar 2026: revenue 4147.79 Cr, profit after tax 709.47 Cr.
What is the promoter holding and pledge in JB Chemicals & Pharmaceuticals Ltd?
Promoter holding is 48.80%; pledged shares are 0.00% of the promoter holding.
Which companies are similar to JB Chemicals & Pharmaceuticals Ltd?
Companies in the same sector of similar size: Emcure Pharmaceuticals Ltd, Ajanta Pharma Ltd, Wockhardt Ltd, GlaxoSmithKline Pharmaceuticals Ltd, IPCA Laboratories Ltd, Gland Pharma Ltd.
Want more history and detail? Create a free account for the full price history, quarterly statements, balance sheet and cash flow.

Figures computed 2026-10-23.